Trial intelligence / Profile preview

Imrecoxib in Knee Osteoarthritis

NCT01985165Phase 4Unknown

Sponsor
Hengrui
Start
May 2013
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of imrecoxib in osteoarthritis (OA), sponsored by Hengrui. Status: unknown.

02

Drugs

imrecoxib
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01985165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01985165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call